Your browser doesn't support javascript.
loading
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas.
Eroglu, Z; Tawbi, H A; Hu, J; Guan, M; Frankel, P H; Ruel, N H; Wilczynski, S; Christensen, S; Gandara, D R; Chow, W A.
  • Eroglu Z; City of Hope National Medical Center, Duarte, CA, USA.
  • Tawbi HA; University of Pittsburgh Cancer Institute and University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Hu J; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
  • Guan M; City of Hope National Medical Center, Duarte, CA, USA.
  • Frankel PH; City of Hope National Medical Center, Duarte, CA, USA.
  • Ruel NH; City of Hope National Medical Center, Duarte, CA, USA.
  • Wilczynski S; City of Hope National Medical Center, Duarte, CA, USA.
  • Christensen S; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
  • Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
  • Chow WA; City of Hope National Medical Center, Duarte, CA, USA.
Br J Cancer ; 112(10): 1644-51, 2015 May 12.
Article en En | MEDLINE | ID: mdl-25897676
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article